Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1998-03-02
2000-04-18
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
5142265, 514420, 514570, A61K 3160, A61K 3154, A61K 3140, A61K 3119
Patent
active
06051566&
ABSTRACT:
Non-steroidal anti-inflammatory drugs proved to be effective drugs for combating and preventing asthma if administered by inhalation. Useful are for instance acetylsalicylic acid, and indomethacin, and ketoprofen, and tenoxicam. Suitable pharmaceutical compositions for inhalation are aerosols with a particle size of from 0.5 .mu.m to 7 .mu.m which enter the compartments of the lungs. Aqueous or aqueous-organic solutions or suspensions can be nebulized in combination with propelling agents, or mixtures of powders with microfine drugs can be administered using inhalers. These pharmaceutical compositions may comprise appropriate additives, in order to improve their relevant pharmaceutical properties.
REFERENCES:
patent: 5244899 (1993-09-01), Mueller et al.
The Merck Index, Eleventh edition, pp. 1441, cit#9080, 1989.
Martindale The Extra Pharmacopoeia, 28th ed., pp. 234-282, 1982.
Carnimeo et al., Allergol. Et. Immunopathol., 9(1)(1-8), 1981.
Pasargiklian et al., Respiration 34:79-91 (1977).
F. Egede, "Fatalt forlobende astmatisk reaktion efter keptoprofen (AlreumRTM.), (Orudis.RTM.), " Ugeskrift for Leager, 141(17): 1151-1152 (1979).
M. Robuschi et al., "Tollerabilita del Tenoxicam Negli Asmatici Aspirino-Sensibili," Giornale Italiano della Malattie del Torace, 40(1): 17-23 (1986).
A. Szczeklik, "Anti-cyclo-oyxgenase Agents and Asthma," J. Asthma, 20(S-1): 23-29 (1983).
A. Szczeklik, "Analgesics Allergy and Asthma," Drugs, 32(Suppl. 4): 146-163 (1986).
A. Szczeklik et al., "Asthma and Anti-inflammatory Drugs: Mechanisms and Clinical Patterns," Current Therapeutics, 24(9): 11-19 (1983).
A.J. Fairfax et al., "The Late Reaction Following Bronchial Provocation with House Dust Mite Allergen. Dependence on Arachiodonic Acid Metabolism," Clin. Exp. Immunol, 52: 393-398 (1983).
A. Szczeklik, "Analgesics, Allergy and Asthma," Br. J. Clin. Pharmac., 10(Suppl. 2): 401S-405S (1980).
J. Kreukniet, "Inhalatiecorticosteroiden bij Astma," Farmacotherapie, vol. 132, (1989), pp. 177-179.
H. Gong et al., "Alcohol-induced Bronchospasm in an Asthmatic patient," Cardiopulmonary J. Chest, vol. 80, (1981), pp. 167-173.
M. Robuschi et al., "Inhaled Frusemide is Highly Effective in Preventing Ultrasonically Nebulised Water Bronchoconstriction, " Pulmonary Pharmacology, vol. 1, (1989), pp. 187-191.
M.L. Kowalski et al., "Clinical Efficacy of Aspirin in `Desensitized` Aspirin Sensitive Asthmatics," Eur. J. Rerspir. Dis., vol. 69, (1986), pp. 219-225.
S. Bianco et al., "Bronchial Response to Nonsteroidal Anti-inflammatory Drugs in Athmatic Patients," Prog. Biochem. Pharmacol., vol. 20, (1985), pp. 132-142.
J.T. Chui, "Improvement in Aspirin-sensitive Asthmatic Subjects After Rapid Aspirin Densitization and Aspirin Maintenance (AdAM) Treatment, " J. Allergy Clin. Immunol., vol. 71, (1983), pp. 560-567.
A.J. Farifax, "Inhibition of the Late Asthmatic Response to House Dust Mite by Non-steroidal Anti-inflamatory Drugs," Prostaglandins Leuhotrienes and Medicine, vol. 8 (1982), pp. 239-248.
B.S.D. Bio Science Development SNC DI Omini C. & Zuccari G.
Henley III Raymond
LandOfFree
Anti-reactive anti-asthmatic activity of non-steroidal anti-infl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-reactive anti-asthmatic activity of non-steroidal anti-infl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-reactive anti-asthmatic activity of non-steroidal anti-infl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336485